Cornea/External Disease News

Treatment with stem cells may be among the considerations in patients with ocular surface disease who have not responded to traditional therapy, according to a speaker at the Twin Cities Ocular Surface Disease Symposium.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John A. Hovanesian, MD, FACS, discusses the benefits of using Iheezo as an anesthetic for cataract and other anterior segment surgeries.

SAN FRANCISCO — Techniques for pterygium excision have not changed significantly from the past, but data from cumulative experience show that conjunctival autograft in combination with surgical excision has the lowest recurrence rate.

A multidisciplinary approach is key to treating patients with corneal nerve dysfunction and neuropathic ocular pain, according to a speaker at Twin Cities Ocular Surface Disease Symposium.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John D. Sheppard, MD, MMSc, discusses Miebo for the treatment of dry eye disease.

SAN FRANCISCO — Dry eye is an umbrella term that covers multiple etiologies and different presentations.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Aziz Mottiwala of Tarsus Pharmaceuticals discusses Xdemvy for the treatment of Demodex blepharitis.

In-office procedures are an integral part of modern dry eye disease management for general practices and specialty clinics alike.

NEW ORLEANS — Using hypotonic riboflavin to induce swelling in the cornea can protect patients with keratoconus from endothelial toxicity during crosslinking, according to Julia Yu, at Academy ’23.

The recent FDA warning about 26 potentially contaminated eye drop products, including some marketed under CVS Health, Leader, Rugby, Rite Aid, Target Up&Up and Velocity Pharma, may have caused some confusion among consumers.